Sofianne Gabrielli

1.3k total citations
56 papers, 743 citations indexed

About

Sofianne Gabrielli is a scholar working on Immunology and Allergy, Rheumatology and Pharmacology. According to data from OpenAlex, Sofianne Gabrielli has authored 56 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology and Allergy, 20 papers in Rheumatology and 18 papers in Pharmacology. Recurrent topics in Sofianne Gabrielli's work include Food Allergy and Anaphylaxis Research (30 papers), Drug-Induced Adverse Reactions (18 papers) and Urticaria and Related Conditions (17 papers). Sofianne Gabrielli is often cited by papers focused on Food Allergy and Anaphylaxis Research (30 papers), Drug-Induced Adverse Reactions (18 papers) and Urticaria and Related Conditions (17 papers). Sofianne Gabrielli collaborates with scholars based in Canada, Israel and Brazil. Sofianne Gabrielli's co-authors include Moshe Ben‐Shoshan, Christine McCusker, Xun Zhang, Elena Netchiporouk, Edmond S. Chan, Ann E. Clarke, Michelle Le, Xun Zhang, Connor Prosty and Judy Morris and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Journal of Allergy and Clinical Immunology.

In The Last Decade

Sofianne Gabrielli

51 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofianne Gabrielli Canada 14 272 169 162 149 141 56 743
Denisa Ferastraoaru United States 11 149 0.5× 188 1.1× 103 0.6× 50 0.3× 87 0.6× 37 504
Siddharth Shah United States 12 136 0.5× 107 0.6× 58 0.4× 13 0.1× 104 0.7× 39 589
Adile Berna Dursun Türkiye 18 198 0.7× 471 2.8× 140 0.9× 125 0.8× 119 0.8× 53 962
Ramit Maoz‐Segal Israel 9 84 0.3× 43 0.3× 40 0.2× 116 0.8× 70 0.5× 22 489
Raymond A. Harvey United States 12 54 0.2× 33 0.2× 40 0.2× 83 0.6× 178 1.3× 26 575
Bob Geng United States 14 111 0.4× 53 0.3× 88 0.5× 62 0.4× 18 0.1× 52 492
Louise Jones United Kingdom 12 38 0.1× 56 0.3× 29 0.2× 14 0.1× 63 0.4× 18 933
B Z Garty Israel 11 93 0.3× 16 0.1× 24 0.1× 89 0.6× 19 0.1× 20 436
Masayuki Hojo Japan 15 104 0.4× 12 0.1× 28 0.2× 26 0.2× 240 1.7× 103 840

Countries citing papers authored by Sofianne Gabrielli

Since Specialization
Citations

This map shows the geographic impact of Sofianne Gabrielli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofianne Gabrielli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofianne Gabrielli more than expected).

Fields of papers citing papers by Sofianne Gabrielli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofianne Gabrielli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofianne Gabrielli. The network helps show where Sofianne Gabrielli may publish in the future.

Co-authorship network of co-authors of Sofianne Gabrielli

This figure shows the co-authorship network connecting the top 25 collaborators of Sofianne Gabrielli. A scholar is included among the top collaborators of Sofianne Gabrielli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofianne Gabrielli. Sofianne Gabrielli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prosty, Connor, Sofianne Gabrielli, Kathryn S. Torok, et al.. (2025). Markers of Type 2 Inflammation and Immunosenescence Are Upregulated in Localized Scleroderma. International Journal of Molecular Sciences. 26(3). 1258–1258.
2.
Gabrielli, Sofianne, Connor Prosty, Elham Rahme, et al.. (2024). Prevalence of omalizumab-resistant chronic urticaria and real-world effectiveness of dupilumab in patients with omalizumab-refractory chronic urticaria: a single-centre experience. Clinical and Experimental Dermatology. 49(10). 1227–1231. 6 indexed citations
3.
Le, Michelle, Sofianne Gabrielli, Elena Netchiporouk, et al.. (2024). Prevalence of atopic conditions in children with chronic urticaria. The Journal of Allergy and Clinical Immunology In Practice. 12(9). 2534–2536.e2.
4.
Nguyen, Alex, Connor Prosty, Sofianne Gabrielli, et al.. (2023). Safety of COVID-19 mRNA vaccination in children with chronic urticaria. The Journal of Allergy and Clinical Immunology In Practice. 11(4). 1310–1313.e2. 4 indexed citations
5.
Prosty, Connor, Sofianne Gabrielli, Ann E. Clarke, et al.. (2022). Impact of Reaction Setting on the Management, Severity, and Outcome of Pediatric Food-Induced Anaphylaxis: A Cross-Sectional Study. The Journal of Allergy and Clinical Immunology In Practice. 10(12). 3163–3171. 4 indexed citations
6.
Jfri, Abdulhadi, et al.. (2022). Systemic Disease Association With Multiple Eruptive Dermatofibromas: A Systematic Review. Journal of Cutaneous Medicine and Surgery. 26(6). 628–629.
7.
Gabrielli, Sofianne, et al.. (2022). Omalizumab for the Treatment of Bullous Pemphigoid: A Systematic Review of Efficacy and Safety. Journal of Cutaneous Medicine and Surgery. 26(4). 404–413. 15 indexed citations
8.
Prosty, Connor, Sofianne Gabrielli, Laura Miles, et al.. (2022). Cold urticaria in a pediatric cohort: Clinical characteristics, management, and natural history. Pediatric Allergy and Immunology. 33(3). e13751–e13751. 8 indexed citations
9.
Prosty, Connor, Sofianne Gabrielli, Sharon Baum, et al.. (2022). Validation of the Urticaria Control Test (UCT) in Children With Chronic Urticaria. The Journal of Allergy and Clinical Immunology In Practice. 10(12). 3293–3298.e2. 13 indexed citations
10.
Miles, Laura, Sofianne Gabrielli, Michelle Le, et al.. (2021). Clinical Characteristics, Management, and Natural History of Chronic Inducible Urticaria in a Pediatric Cohort. International Archives of Allergy and Immunology. 182(8). 757–764. 11 indexed citations
11.
Miles, Laura, Sofianne Gabrielli, Elissa M. Abrams, et al.. (2021). Community Use of Epinephrine for the Treatment of Anaphylaxis: A Review and Meta-Analysis. The Journal of Allergy and Clinical Immunology In Practice. 9(6). 2321–2333. 39 indexed citations
12.
Gabrielli, Sofianne, Ann E. Clarke, Judy Morris, et al.. (2021). Fruit-Induced Anaphylaxis: Clinical Presentation and Management. The Journal of Allergy and Clinical Immunology In Practice. 9(7). 2825–2830.e2. 19 indexed citations
13.
Clarke, Ann E., Sofianne Gabrielli, Judy Morris, et al.. (2020). Risk of peanut- and tree-nut–induced anaphylaxis during Halloween, Easter and other cultural holidays in Canadian children. Canadian Medical Association Journal. 192(38). E1084–E1092. 4 indexed citations
14.
Gabrielli, Sofianne, Michelle Le, Elena Netchiporouk, et al.. (2020). Chronic urticaria in children can be controlled effectively with updosing second-generation antihistamines. Journal of the American Academy of Dermatology. 82(6). 1535–1537. 18 indexed citations
15.
Gabrielli, Sofianne, et al.. (2020). Rates of anaphylaxis for the most common food allergies. The Journal of Allergy and Clinical Immunology In Practice. 8(7). 2402–2405.e3. 14 indexed citations
16.
Molloy, John, Sofianne Gabrielli, Ann E. Clarke, et al.. (2019). Anaphylaxis: comparison of clinical characteristics and management between children less than 2 years of age and older children. Journal of Allergy and Clinical Immunology. 143(2). AB145–AB145. 1 indexed citations
17.
Gabrielli, Sofianne, Ann E. Clarke, Judy Morris, et al.. (2019). When and how pediatric anaphylaxis cases reach the emergency department: Findings from the Cross-Canada Anaphylaxis Registry. The Journal of Allergy and Clinical Immunology In Practice. 8(4). 1406–1409.e2. 7 indexed citations
18.
Le, Michelle, Sofianne Gabrielli, Sarah De Schryver, & Moshe Ben‐Shoshan. (2019). <p>Management Strategies Of Idiopathic Anaphylaxis In The Emergency Room: Current Perspectives</p>. Open Access Emergency Medicine. Volume 11. 249–263. 3 indexed citations
19.
Gabrielli, Sofianne, et al.. (2018). Omalizumab for management of chronic urticaria in a pediatric population: a case-series. Journal of Allergy and Clinical Immunology. 141(2). AB55–AB55. 2 indexed citations
20.
Gabrielli, Sofianne, Ann E. Clarke, Judy Morris, et al.. (2018). Teenagers and those with severe reactions are more likely to use their epinephrine autoinjector in cases of anaphylaxis in Canada. The Journal of Allergy and Clinical Immunology In Practice. 7(3). 1073–1075.e3. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Denisa Ferastraoaru Breakdown of academic impact, for papers by Siddharth Shah Breakdown of academic impact, for papers by Adile Berna Dursun Breakdown of academic impact, for papers by Ramit Maoz‐Segal Breakdown of academic impact, for papers by Raymond A. Harvey Breakdown of academic impact, for papers by Bob Geng Breakdown of academic impact, for papers by Louise Jones Breakdown of academic impact, for papers by B Z Garty Breakdown of academic impact, for papers by Masayuki Hojo
Rankless by CCL
2026